Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma
Status:
Recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
The optimal first-line treatment for extra-nodal NK/T-cell lymphoma (ENKTL) has not been
well-defined. This phase II study aimed to evaluate the efficacy and safety of pegaspargase,
cyclophosphamide, vincristine, etoposide and prednisone (COEPL) regimen combined with
radiotherapy for patients with newly diagnosed ENKTL.
Phase:
Phase 2
Details
Lead Sponsor:
Peking University
Collaborators:
Beijing Cancer Hospital Hebei Medical University Fourth Hospital Jiangxi Provincial Cancer Hospital Peking University International Hospital